0 CommentsWhen I last wrote about Global Indemnity P.L.C., it was one of several companies incorporating in the more tax-friendly climate of Ireland... Read more
0 CommentsThere is little agreement over what the U.S. employer-based health-insurance system will look like 10 years from now. Some have speculated... Read more
0 CommentsEndo Pharmaceuticals Holdings Inc. chief executive David P. Holveck was described Monday at a Pennsylvania Bio event as an “icon”... Read more
0 CommentsAvid Radiopharmaceuticals Inc. will be bought by Eli Lilly & Co. in a deal valued at up to $800 million. Shareholders in the privately... Read more
0 CommentsIt can be disastrous for a small drug developer to have a deep-pocketed partner walk away from a partnership on an experimental therapy. Such... Read more
0 CommentsIt’s not often a company with more than $800 million in annual sales establishes its headquarters in Philadelphia. Even rarer is one... Read more
Inquirer business columnist Mike Armstrong and other staff writers take you beyond the business headlines in Philadelphia.